AgeX Therapeutics Inc
Research AgeX Therapeutics Inc (SER) on Bullrun: market cap USD 29.55M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSER
- ExchangeNYSE MKT
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 29.55M
- Financial periodFY2025
- RevenueUSD 130.00K
- Revenue growth132.1%
- Net income-USD 19.18M
- Free cash flow-USD 18.01M
Valuation Snapshot
latest market cap is USD 29.55M.
About AgeX Therapeutics Inc
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles.
Frequently asked questions
What is AgeX Therapeutics Inc's market cap?
AgeX Therapeutics Inc's market capitalization is USD 29.55M.
What does AgeX Therapeutics Inc do?
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial;